All articles tagged: Schizophrenia (F20)
HealthDay
23 January at 04.13 PM
Severe QT Prolongation Common in Users of Antipsychotic MedicationsMore than one in eight patients receiving quetiapine or haloperidol therapy appear to develop severe QT prolongation (SQTP), according to a study published online Jan. 14 in Heart Rhythm.Chun-Li Wang, M.D., from the Linkou Medical Center in Taoyuan, Taiwan, and colleagues examined the incidences, risk factors, and outcomes of SQTP |
|
HealthDay
16 January at 04.59 AM
Many With Psychosis Have Long-Term Functional MorbidityA diagnosis of psychosis in adolescence is associated with long-term functional morbidity, meeting the criteria for not being in education, employment, and training (NEET), according to a study published online Oct. 28 in Schizophrenia Bulletin.Ida Ringbom, M.D., from the University of Turku in Finland, and colleagues examined risk fact |
Evalytics
18 December at 06.28 PM
Kids with cats have more than double the risk of developing schizophrenia, researchers findA study indicates that childhood exposure to cats may slightly raise the risk of developing schizophrenia later in life. This elevated risk is attributed to potential exposure to the Toxoplasma gondii parasite carried by cats but is only one of several contributing factors to the disorder. |
|
HealthDay
08 December at 04.30 PM
Tardive Dyskinesia Impacts Patients and CaregiversTardive dyskinesia (TD) poses a substantial burden for both caregivers and patients, according to a study published online Nov. 28 in the Journal of Patient-Reported Outcomes.Rakesh Jain, M.D., M.P.H., from the Texas Tech University School of Medicine-Permian Basin in Midland, and colleagues conducted an online survey to assess pati |
|
HealthDay
06 December at 04.49 PM
Brain Stimulation Can Improve Prospective Memory in SchizophreniaFor patients with schizophrenia, bilateral high-frequency repetitive transcranial magnetic stimulation (rTMS) can improve event-based prospective memory (EBPM), according to a study published online Dec. 6 in Neuropsychopharmacology Reports.Fen Xue, from the Mental Health Hospital in Beijing, and colleagues examined the effects of rTM |
|
HealthDay
30 November at 09.59 PM
Psychiatric Comorbidity Increases Risk for Schizophrenia With ADHDThe presence of psychiatric comorbidity in young patients with attention-deficit/hyperactivity disorder (ADHD) is associated with a higher risk for being diagnosed with schizophrenia, according to a study published online Nov. 30 in JAMA Network Open.Soo Min Jeon, Pharm.D., Ph.D., from Jeju National University in South Korea, and |
|
HealthDay
22 November at 04.44 PM
Semaglutide, Liraglutide May Reduce Hospitalization Risk for Alcohol Use DisorderSemaglutide and liraglutide are associated with a reduced risk for hospitalization due to alcohol use disorder (AUD), according to a study published online Nov. 13 in JAMA Psychiatry.Markku Lähteenvuo, M.D., Ph.D., from the University of Eastern Finland in Kuopio, and colleagues conducted an observational study in Sweden using data from |
Medpage Today
17 November at 10.31 PM
Two Treatments That Don't Work for OsteoarthritisWASHINGTON -- If you're looking for nonsurgical osteoarthritis (OA) treatments with fewer side effects than ordinary pain relievers, two randomized trials presented here with negative results should at least narrow your search... |
MedScape
11 November at 07.56 AM
Scoring System Could Mean Better Access to Lung TransplantScoring system could improve access for hard-to-match candidates due to height and blood type. |
Medical xPress
07 November at 07.50 AM
How key results could influence health policyThe results of some congressional races may foreshadow who will have outsize health policy influence in Congress next year. |
|
Medpage Today
05 November at 07.00 PM
Mpox Cases in Congo May Be StabilizingGOMA, Congo -- Some health officials say mpox cases in Congo appear to be "stabilizing" -- a possible sign that the main epidemic for which the World Health Organization (WHO) made a global emergency declaration in August... |
|
Medical xPress
02 November at 07.40 AM
Insulin resistance caused by sympathetic nervous system over-activation, a paradigm-shifting study findsRutgers Robert Wood Johnson Medical School and collaborating institutions have found that overnutrition leads to insulin resistance and metabolic disorders through increased activity of the sympathetic nervous system (SNS). The study shows that reducing SNS activity can prevent insulin resistance induced by a high-fat diet, suggesting a new understanding of how obesity causes insulin resistance. |
|
|
MedScape
31 October at 06.30 AM
Report: Rethink Race-Based Adjustments in Clinical ToolsThe slow adoption of race-neutral tools may harm patient care outcomes, according to a new report from the National Academies of Sciences, Engineering, and Medicine. |
|
Medpage Today
25 October at 02.09 PM
Patients More Satisfied With AI's Answers Than Those From Their DoctorPatients were consistently more satisfied with responses from artificial intelligence (AI) to messages in the electronic health record than they were with those from their clinician, according to a study in JAMA Network Open... |
|
Medical xPress
25 October at 12.40 PM
Surgical innovation: The intelligent turbine insufflatorThe Politecnico di Milano and the Erasmus Medical Center in Rotterdam have pooled their medical and technical expertise to create a new technology for devices called "insufflators." These innovative instruments are designed to create a temporary cavity in the bodies of patients through the application of pressurized gas, providing the surgeon with the necessary space to perform the surgical proced |
|
Medical xPress
24 October at 07.50 AM
Genetic variants in melatonin receptor linked to idiopathic osteoporosisColumbia University Medical Center researchers have identified specific variants in a melatonin receptor gene that impair bone turnover, leading to significant reductions in bone density and increased risk of fractures, particularly in Ashkenazi Jewish individuals. |
Newsletter for Healtcare
Join over 1.2M subscribers and receive one weekly email.
